Searcharxiv⌕ Search

arXiv subjects

Huifeng Zhao

Publications and source records attributed to Huifeng Zhao.

9 recordsLinked to original sources

CARVE: A glycan-specific framework for assessing protein-glycan binding-pose quality

Protein-glycan interactions depend on the precise three-dimensional arrangement of carbohydrates at protein-binding interfaces, yet reliable assessment of predicted complex structures remains challenging. Existing evaluations commonly rely on fixed root-mean-square deviation (RMSD) thresholds, which do not fully account for the structural diversity and conformational flexibility of glycans. Here we developed CARVE, a glycan-specific framework for evaluating protein-glycan structure predictions. Through topology-aware glycan parsing, CARVE integrates orientation RMSD (oRMSD), interface-ring RMSD (irRMSD) and the fraction of native contacts (Fnat) to assess glycan scaffold geometry, interface-ring placement and native-contact recovery. These descriptors define four quality categories (CARVE-Level) with geometric thresholds that scale with the degree of polymerization (DP), and a continuous CARVE-Score, which reproduced those categories on 25,068 independently generated poses without recalibration (macro-F1 = 0.892). Pairing these measures with glycan-specific topological, chemical and geometric validity checks, we benchmarked nine prediction methods on CARVE-Bench, comprising 1,974 experimentally determined protein-glycan complexes. Among the top 25 predictions per target, HADDOCK3 achieved the highest Acceptable-level success rate (47.0%), whereas no method produced a high-quality, structurally valid pose for more than one in five. Collectively, CARVE provides a standardized basis for assessing protein-glycan structure prediction methods and guiding the development of more accurate docking and co-folding approaches.

q-bio.BM↗

Accurate structural modelling of protein-glycan recognition with GlycoWeave

Protein-glycan recognition underlies diverse biological processes, yet accurate prediction of protein-glycan complex structures remains challenging owing to the chemical diversity, conformational flexibility and sparse experimental structural coverage of glycans. Here we present GlycoWeave, a glycan-specific diffusion framework that integrates chemically constrained conformational sampling, multiscale molecular representations and multi-source learning. By operating in internal-coordinate space, GlycoWeave preserves glycan connectivity and stereochemistry while efficiently exploring bound conformations. A heterogeneous equivariant network couples atom-level interaction geometry with monosaccharide-level structural context, whereas multi-source, multi-head training integrates experimental complexes with structures refined using classical and quantum mechanics-informed potentials. On a benchmark of 698 protein-glycan complexes, GlycoWeave achieves a 71.9% Top-25 high-quality success rate, compared with 19.2% for AlphaFold 3, while requiring only 0.34 s per sampled pose. GlycoWeave further preserves glycan structural validity, recovers native protein-glycan interactions and reproduces linkage-specific conformational preferences, maintaining high accuracy across diverse glycan architectures and protein environments. These results establish GlycoWeave as an accurate, efficient and chemically faithful framework for modelling protein-glycan recognition. GlycoWeave is freely available at https://cadd.zju.edu.cn/glycoweave.

q-bio.BM↗

Navigating committor landscape of biomolecules with a general pairwise interaction model

Sampling rare conformation transitions between metastable states is a central challenge in atomistic simulations. While the committor function serve as an ideal reaction coordinate for driving enhanced sampling, their high-dimensional inputs and complex functional forms limit the efficacy of standard feedforward neural networks in modeling them. Inspired by recent breakthroughs in biomolecular structure prediction, we propose a novel committor learning framework grounded in the AlphaFold 3 paradigm. By integrating a lightweight, differentiable atom-level embedding with a simplified Pairformer architecture, our method inherently captures intricate dynamical features of diverse biosystems without requiring specialized prior knowledge. We demonstrate the superior expressiveness and accuracy of the proposed framework across multiple atomistic processes. For the folding of the chignolin mini-protein, our model reveals the finer-grained structure of its transition state ensemble (TSE) and a detailed bifurcated reaction mechanism. Furthermore, for calixarene host-guest systems, we develop a unified committor model that elucidates how ligand substituents regulate the ratio between distinct binding pathways, offering new perspectives for structure-based drug design.

physics.comp-ph↗

PPFlow: Target-aware Peptide Design with Torsional Flow Matching

Therapeutic peptides have proven to have great pharmaceutical value and potential in recent decades. However, methods of AI-assisted peptide drug discovery are not fully explored. To fill the gap, we propose a target-aware peptide design method called \textsc{PPFlow}, based on conditional flow matching on torus manifolds, to model the internal geometries of torsion angles for the peptide structure design. Besides, we establish a protein-peptide binding dataset named PPBench2024 to fill the void of massive data for the task of structure-based peptide drug design and to allow the training of deep learning methods. Extensive experiments show that PPFlow reaches state-of-the-art performance in tasks of peptide drug generation and optimization in comparison with baseline models, and can be generalized to other tasks including docking and side-chain packing.

q-bio.BM↗

Token-Mol 1.0: Tokenized drug design with large language model

Significant interests have recently risen in leveraging sequence-based large language models (LLMs) for drug design. However, most current applications of LLMs in drug discovery lack the ability to comprehend three-dimensional (3D) structures, thereby limiting their effectiveness in tasks that explicitly involve molecular conformations. In this study, we introduced Token-Mol, a token-only 3D drug design model. This model encodes all molecular information, including 2D and 3D structures, as well as molecular property data, into tokens, which transforms classification and regression tasks in drug discovery into probabilistic prediction problems, thereby enabling learning through a unified paradigm. Token-Mol is built on the transformer decoder architecture and trained using random causal masking techniques. Additionally, we proposed the Gaussian cross-entropy (GCE) loss function to overcome the challenges in regression tasks, significantly enhancing the capacity of LLMs to learn continuous numerical values. Through a combination of fine-tuning and reinforcement learning (RL), Token-Mol achieves performance comparable to or surpassing existing task-specific methods across various downstream tasks, including pocket-based molecular generation, conformation generation, and molecular property prediction. Compared to existing molecular pre-trained models, Token-Mol exhibits superior proficiency in handling a wider range of downstream tasks essential for drug design. Notably, our approach improves regression task accuracy by approximately 30% compared to similar token-only methods. Token-Mol overcomes the precision limitations of token-only models and has the potential to integrate seamlessly with general models such as ChatGPT, paving the way for the development of a universal artificial intelligence drug design model that facilitates rapid and high-quality drug design by experts.

q-bio.BM↗

Deep Lead Optimization: Leveraging Generative AI for Structural Modification

The idea of using deep-learning-based molecular generation to accelerate discovery of drug candidates has attracted extraordinary attention, and many deep generative models have been developed for automated drug design, termed molecular generation. In general, molecular generation encompasses two main strategies: de novo design, which generates novel molecular structures from scratch, and lead optimization, which refines existing molecules into drug candidates. Among them, lead optimization plays an important role in real-world drug design. For example, it can enable the development of me-better drugs that are chemically distinct yet more effective than the original drugs. It can also facilitate fragment-based drug design, transforming virtual-screened small ligands with low affinity into first-in-class medicines. Despite its importance, automated lead optimization remains underexplored compared to the well-established de novo generative models, due to its reliance on complex biological and chemical knowledge. To bridge this gap, we conduct a systematic review of traditional computational methods for lead optimization, organizing these strategies into four principal sub-tasks with defined inputs and outputs. This review delves into the basic concepts, goals, conventional CADD techniques, and recent advancements in AIDD. Additionally, we introduce a unified perspective based on constrained subgraph generation to harmonize the methodologies of de novo design and lead optimization. Through this lens, de novo design can incorporate strategies from lead optimization to address the challenge of generating hard-to-synthesize molecules; inversely, lead optimization can benefit from the innovations in de novo design by approaching it as a task of generating molecules conditioned on certain substructures.

q-bio.BM↗

Deep Geometry Handling and Fragment-wise Molecular 3D Graph Generation

Most earlier 3D structure-based molecular generation approaches follow an atom-wise paradigm, incrementally adding atoms to a partially built molecular fragment within protein pockets. These methods, while effective in designing tightly bound ligands, often overlook other essential properties such as synthesizability. The fragment-wise generation paradigm offers a promising solution. However, a common challenge across both atom-wise and fragment-wise methods lies in their limited ability to co-design plausible chemical and geometrical structures, resulting in distorted conformations. In response to this challenge, we introduce the Deep Geometry Handling protocol, a more abstract design that extends the design focus beyond the model architecture. Through a comprehensive review of existing geometry-related models and their protocols, we propose a novel hybrid strategy, culminating in the development of FragGen - a geometry-reliable, fragment-wise molecular generation method. FragGen marks a significant leap forward in the quality of generated geometry and the synthesis accessibility of molecules. The efficacy of FragGen is further validated by its successful application in designing type II kinase inhibitors at the nanomolar level.

physics.chem-ph↗

Delete: Deep Lead Optimization Enveloped in Protein Pocket through Unified Deleting Strategies and a Structure-aware Network

Drug discovery is a highly complicated process, and it is unfeasible to fully commit it to the recently developed molecular generation methods. Deep learning-based lead optimization takes expert knowledge as a starting point, learning from numerous historical cases about how to modify the structure for better drug-forming properties. However, compared with the more established de novo generation schemes, lead optimization is still an area that requires further exploration. Previously developed models are often limited to resolving one (or few) certain subtask(s) of lead optimization, and most of them can only generate the two-dimensional structures of molecules while disregarding the vital protein-ligand interactions based on the three-dimensional binding poses. To address these challenges, we present a novel tool for lead optimization, named Delete (Deep lead optimization enveloped in protein pocket). Our model can handle all subtasks of lead optimization involving fragment growing, linking, and replacement through a unified deleting (masking) strategy, and is aware of the intricate pocket-ligand interactions through the geometric design of networks. Statistical evaluations and case studies conducted on individual subtasks demonstrate that Delete has a significant ability to produce molecules with superior binding affinities to protein targets and reasonable drug-likeness from given fragments or atoms. This feature may assist medicinal chemists in developing not only me-too/me-better products from existing drugs but also hit-to-lead for first-in-class drugs in a highly efficient manner.

q-bio.BM↗

Infinite Physical Monkey: Do Deep Learning Methods Really Perform Better in Conformation Generation?

Conformation Generation is a fundamental problem in drug discovery and cheminformatics. And organic molecule conformation generation, particularly in vacuum and protein pocket environments, is most relevant to drug design. Recently, with the development of geometric neural networks, the data-driven schemes have been successfully applied in this field, both for molecular conformation generation (in vacuum) and binding pose generation (in protein pocket). The former beats the traditional ETKDG method, while the latter achieves similar accuracy compared with the widely used molecular docking software. Although these methods have shown promising results, some researchers have recently questioned whether deep learning (DL) methods perform better in molecular conformation generation via a parameter-free method. To our surprise, what they have designed is some kind analogous to the famous infinite monkey theorem, the monkeys that are even equipped with physics education. To discuss the feasibility of their proving, we constructed a real infinite stochastic monkey for molecular conformation generation, showing that even with a more stochastic sampler for geometry generation, the coverage of the benchmark QM-computed conformations are higher than those of most DL-based methods. By extending their physical monkey algorithm for binding pose prediction, we also discover that the successful docking rate also achieves near-best performance among existing DL-based docking models. Thus, though their conclusions are right, their proof process needs more concern.

q-bio.BM↗